Correlation Between Rallybio Corp and Molecular Partners

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rallybio Corp and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rallybio Corp and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rallybio Corp and Molecular Partners AG, you can compare the effects of market volatilities on Rallybio Corp and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rallybio Corp with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rallybio Corp and Molecular Partners.

Diversification Opportunities for Rallybio Corp and Molecular Partners

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Rallybio and Molecular is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Rallybio Corp and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Rallybio Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rallybio Corp are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Rallybio Corp i.e., Rallybio Corp and Molecular Partners go up and down completely randomly.

Pair Corralation between Rallybio Corp and Molecular Partners

Given the investment horizon of 90 days Rallybio Corp is expected to generate 0.47 times more return on investment than Molecular Partners. However, Rallybio Corp is 2.15 times less risky than Molecular Partners. It trades about 0.03 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.08 per unit of risk. If you would invest  104.00  in Rallybio Corp on August 28, 2024 and sell it today you would earn a total of  1.00  from holding Rallybio Corp or generate 0.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rallybio Corp  vs.  Molecular Partners AG

 Performance 
       Timeline  
Rallybio Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rallybio Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Molecular Partners 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Molecular Partners is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Rallybio Corp and Molecular Partners Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rallybio Corp and Molecular Partners

The main advantage of trading using opposite Rallybio Corp and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rallybio Corp position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.
The idea behind Rallybio Corp and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account